P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells

Ítems similars

• A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells
  per: van Loenen, Marleen M., et al.
  Publicat: (2014)
• Extracellular Domains of CD8α and CD8ß Subunits Are Sufficient for HLA Class I Restricted Helper Functions of TCR-Engineered CD4(+) T Cells
  per: van Loenen, Marleen M., et al.
  Publicat: (2013)
• Allo‐reactive T cells for the treatment of hematological malignancies
  per: Falkenburg, J.H.F., et al.
  Publicat: (2015)
• HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
  per: van Balen, Peter, et al.
  Publicat: (2020)
• HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
  per: Peter van Balen, et al.
  Publicat: (2020-08-01)